Table 3.
Summary of outcomes for postoperative radiotherapy in IIA/N0 esophageal cancer
| Study | Pathology | Stage | Treatment | Sample size | Median OS, months | 3‐year OS, % | 5‐year OS, % | p value |
|---|---|---|---|---|---|---|---|---|
| Schreiber et al. 7 | AC and SCC | IIA (T3N0) | PORT | 69 | 46 | 51.9 | — | .245 |
| Surgery | 190 | 27 | 46.4 | — | ||||
| Worni et al. 14 | SCC | IIA | PORT | 44 | 35 | — | 35.0 | >.05 |
| Surgery | 216 | 21 | — | 28.5 | ||||
| Wong et al. 9 | AC and SCC | T3–4Nx/0 | PORT | 217 | — | 41.3 | — | .24 |
| Surgery | 1148 | — | 46.9 | — |
Abbreviations: —, no data; AC, adenocarcinoma; OS, overall survival; PORT, postoperative radiotherapy; SCC, squamous cell carcinoma.